Latest Regulatory News

Midas Minerals has reported a significant new high-grade copper and silver find at its Spaatzu Prospect within Namibia’s Otavi Copper Project, marking a promising expansion near the established T-13 deposit.

Electro Optic Systems (EOS) has acquired European defence tech firm MARSS, integrating advanced AI-enabled command and control systems to create a comprehensive counter-drone solution. This strategic move positions EOS as a prime contractor for larger defence programs and expands its global footprint.

Tamboran Resources has appointed Todd Abbott as CEO, bringing over 25 years of upstream oil and gas expertise to lead its pivotal Beetaloo Basin development.

ReNerve Limited has secured broader regulatory approval in Hong Kong for its NervAlign® Nerve Cuff, enabling access to both public and private hospitals and validating the device’s clinical benefits through independent review.

Clinuvel Pharmaceuticals has initiated dosing in a preclinical study of its novel controlled-release injectable peptide platform, VLRX-L, aiming to enhance drug delivery for melanocortin-based therapies. Preliminary results are expected in the second half of 2026.

Imricor Medical Systems has achieved a major milestone with FDA clearance for its Vision-MR Diagnostic Catheter, paving the way for commercial sales in the US electrophysiology market.

Haranga Resources has confirmed a significant continuous gold mineralised trend exceeding 800 metres at its Ibel South Gold Project in Senegal, with plans for deeper drilling in early 2026 to explore high-grade zones and untested anomalies.

Augustus Minerals has secured heritage approval for drilling at its Music Well Gold Project, paving the way for a maiden 1,000-metre drilling campaign targeting the promising Clifton East prospect in early 2026.

Aristocrat Leisure and Light & Wonder have resolved their high-profile intellectual property litigation with a $190 million settlement and the withdrawal of disputed games from the market.

Pharmaceutical manufacturer ANO has been hit with a US FDA Import Alert, joining several Australian peers amid wider regulatory tensions. The company is mobilising expert consultants and preparing a petition to lift the alert within weeks.

Skylark Minerals Limited has applied for ASX quotation of 37.98 million fully paid ordinary shares from a previously approved placement, signalling a key step in its capital expansion strategy.

Mesoblast Limited reports a 60% jump in Ryoncil sales for the December quarter, underpinned by a new $125 million financing facility that strengthens its balance sheet and strategic flexibility.